IRX Therapeutics
Developing immune therapies to activate the body's natural defense against cancer and related diseases, aiming to enhance and extend patient lives.
General Information
BounceWatch is an independent company data service, not affiliated with IRX Therapeutics. To contact IRX Therapeutics, visit brooklynitx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does IRX Therapeutics compare?
A PDF of IRX Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting IRX Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is IRX Therapeutics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About IRX Therapeutics
Business keywords: Immune therapy, Cancer treatment, IRX-2, New York-based, Immune system activation, Cancer immunotherapy, Patient-focused, Biopharmaceutical, Immune function restoration
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $33.23M | - |
|
29 Aug 2017 |
| Debt Financing | $2.00M | - |
|
12 May 2016 |
| Venture Round | $40.59M | - |
|
17 Aug 2015 |
| Debt Financing | $15.09M | - |
|
17 Mar 2014 |
| Debt Financing | $1.50M | - |
|
30 May 2012 |
| Debt Financing | $8.05M | - |
|
11 Jun 2010 |
| Venture Round | $2.21M | - |
|
06 Jan 2010 |
| Series A | $25.00M | - |
|
04 Jun 2008 |
IRX Therapeutics Alternatives & Competitors
View All Alternatives
Developing the next generation of patient specific neoantigen-targeting cancer immunotherapies, one...
Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mechanisms of...
Focused on harnessing the immune system to achieve deep and durable clinical responses to improve th...
Shinobi Therapeutics
FAQ About IRX Therapeutics
Source: BounceWatch company record for IRX Therapeutics, https://bouncewatch.com/company/irx-therapeutics, updated 9 November 2024. When citing, please name BounceWatch and link this page.
